Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 7, Issue 11 (2018)

Lipid disorders

Author(s):
Chitra Prabhakar and V Paul
Abstract:
Lipid disorders have a broad spectrum of metabolic conditions that affect blood lipid levels. They are generally characterized by elevated levels of cholesterol, triglycerides, and/or lipoproteins in the blood in association with an increased risk of cardiovascular disease. The majority of lipid disorders are common because of unhealthy lifestyles (obesity, inactivity, alcoholism). Congenital causes are less common; like familial hypertriglyceridemia, is associated with extremely high levels of triglycerides that significantly increase the risk of pancreatitis in human, and familial hypercholesterolemia that results early atherosclerotic complications. Lipid disorders are usually detected during the time of routine laboratory testing, such as cardiovascular risk factor screening. The blood lipid profile includes all total cholesterol, LDL, HDL, and triglycerides. A fasting lipid profile must show pathological values on two different occasions to confirm the diagnosis. Dyslipidemia is diagnosed if LDL levels > 130 mg/dL and/or HDL levels < 40 mg/dL. The management of lipid disorders involves lifestyle modifications and lipid-lowering agents (primarily statins).
Pages: 103-106  |  203 Views  16 Downloads
How to cite this article:
Chitra Prabhakar and V Paul. Lipid disorders. The Pharma Innovation Journal. 2018; 7(11): 103-106.
Journals List Click Here Research Journals Research Journals
Call for book chapter